Recorded with
Good afternoon everyone this is sarah archiness your clinical pharmacist welcome to episode number 88 of pharmacy education corner today i’ll be discussing another medication in summary for you the name of the medication is toilet or eleven or gestural and ethynel estradiol it’s from agile therapeutics it was fda approved on february 14 2020. i’ve included a picture
Of the wheel over here for you to see this medication is a combination of lemon registry le progestin and estradiol an estrogen indicated as a method of contraception for using women of reproductive age and potential with a bmi less than 30 for whom a combined hormonal contraceptive is appropriate this medication um i am just like an inconvenient combination
Hormonal contraceptives lower the risk of becoming pregnant primarily and by suppressing the ovulation and it comes in a transdermal system 120 microgram per day elemental gesturing and 30 microgram per day 18l estrada as you see the patch is over here for transmitter transdermal use only obviously apply one transdermal system patch every week for three consecutive
Weeks um it’s going to apply to rela to one of the following sites abdomen buttock um upper torso and it’s very important for the patients to know not to cut or alter the transdermal patch in any way possible most common side effects seen from this medication foreign especially in clinical trials included nausea headache dysmenorrhea and increased weight if it’s
Important for the patients to know about the side effects and if they experience any of them to refer back to their specialist or primary care physician or pharmacist uh for follow-up the safety of torila was evaluated in a 12-month multi-center open label single alarm clinical trial conducted in the united states and the women applied to for 13 28 day treatment
Cycles uh one treatment cycle is defined as a three consecutive weeks and that one thriller transplant their little patch is applied for seven day where followed by one week and that twilight is not applied the safety population for these clinical trials was composed of over 2000 women and and the median mean mh for these patients were about 27 years old based
On this study and a few other studies toerla or levonor gestural and ethel estrada was approved from agile therapeutics on february 14 2020 and as a convenient combination of hormonal therapy and for contraception indicated as a method for contraception for using women of a reproductive age with bmi less than uh 30 am and um for those and that use of this kind
Of combination hormonal contraceptives is um appropriate um this is a summary information about torila for more detailed information please refer back to the package insert which is available online from the agile therapeutics uh hope you enjoyed this video as always stay safe and take your medications
Transcribed from video
Twirla (levonorgestrel/Ethinyl Estradiol)- Contraceptive- by Saro Arakelians, PharmD- Episode # 88 By Pharmacist Education Corner- by Saro Arakelians
